Overview

Regadenoson and Adenosine

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to test the accuracy of Regadenoson to induce maximal and steady state hyperemia as compared to central venous infusion of adenosine for assessing fractional flow reserve. (adenosine is considered to be the gold standard)and to investigate the time intervals of maximum hyperemia induced by centrally and peripherally administered Regadenoson.
Phase:
Phase 3
Details
Lead Sponsor:
Lokien van Nunen
Treatments:
Adenosine
Regadenoson